These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10378346)

  • 1. Psychological issues in genetic testing for breast cancer.
    Carter CL; Hailey BJ
    Women Health; 1999; 28(4):73-91. PubMed ID: 10378346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP
    Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
    Hamann U
    Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for inherited susceptibility to breast cancer: a survey of informed consent forms for BRCA1 and BRCA2 mutation testing.
    Durfy SJ; Buchanan TE; Burke W
    Am J Med Genet; 1998 Jan; 75(1):82-7. PubMed ID: 9450863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk assessment for familial occurrence of breast cancer].
    Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
    Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
    Ardern-Jones A; Kenen R; Eeles R
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral risk factors among women presenting for genetic testing.
    Emmons KM; Kalkbrenner KJ; Klar N; Light T; Schneider KA; Garber JE
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):89-94. PubMed ID: 10667468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.
    Tercyak KP; Lerman C; Peshkin BN; Hughes C; Main D; Isaacs C; Schwartz MD
    Health Psychol; 2001 May; 20(3):217-22. PubMed ID: 11403219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological impact of receiving a BRCA1/BRCA2 test result.
    Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF
    Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility for breast cancer: testing and primary prevention options.
    Baron RH; Borgen PI
    Oncol Nurs Forum; 1997 Apr; 24(3):461-8. PubMed ID: 9127359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest in genetic testing among first-degree relatives of breast cancer patients.
    Lerman C; Seay J; Balshem A; Audrain J
    Am J Med Genet; 1995 Jul; 57(3):385-92. PubMed ID: 7677139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Support groups for people carrying a BRCA mutation.
    Dorval M; Maunsell E; Dugas MJ; Simard J
    CMAJ; 2001 Sep; 165(6):740; author reply 740, 742. PubMed ID: 11584558
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
    Rebbeck TR
    J Clin Oncol; 2000 Nov; 18(21 Suppl):100S-3S. PubMed ID: 11060335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
    Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for cancer: a complex decision.
    Harv Womens Health Watch; 2001 Feb; 8(6):2-4. PubMed ID: 11175466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.